Thu, Jul 20, 2023
Krsnaa Diagnostics stock slumped more than 12 per cent on Thursday after National Health Mission, Rajasthan cancelled their contract for providing laboratory services in the state.
More >
Wed, Apr 20, 2022
According to brokerage firm IIFL Securities, “The Indian diagnostics industry offers consistent and long-term growth potential of around 11-12 per cent, and national diagnostic chains would continue to outperform industry growth.”
Tue, Apr 05, 2022
Given increasing health awareness post-Covid, a higher share of wellness, specialized, and home collection segments will continue to aid realizations, the brokerage said.
Mon, Mar 07, 2022
Pallavi Jain, Managing Director (MD), Krsnna Diagnostics Ltd., speaks about her journey at the helm of the company, scenario of health screenings of the women, Q3FY22 numbers, patients & Tests Volumes.
Tue, Oct 12, 2021
Krsnaa Diagnostics stocks hit a new 52-week low of Rs 726 on Tuesday after the company Q2FY22 results reported a decline in Profit After Tax (PAT)
Mon, Aug 16, 2021
The shares of newly listed companies — Krsnaa Diagnostics, Exxaro Tiles, and Windlas Biotech — ended mixed and all witnessed a marginal profit booking on the first day of listing on Monday.
Shares of Krsnaa Diagnostics got listed at Rs 1,025, reflecting a jump of 7.44 per cent from the issue price on the BSE.
In line with the expectations of Zee Business Managing Editor Anil Singhvi, the shares of Devyani International made a bumper debut of over 55 per cent higher premium to above Rs 140 per share on both NSE and BSE as compared to the issue price of Rs 90 per share at the upper end.
Zee Business Managing Editor and the market guru Anil Singhvi expects a bumper listing for all these IPOs today.
Devyani International IPO, Krsnaa Diagnostics IPO, Windlas Biotech IPO and Exxaro Tiles, which will make their debut on bourses today, have opened for subscription on August 4 and closed on August 6
Thu, Aug 12, 2021
Krsnaa Diagnostics IPO – The finalisation of share allotment of Krsnaa Diagnostics Limited Initial Public Offering (IPO) is expected to be completed by today.
Tue, Aug 10, 2021
Krsnaa Diagnostics IPO – The Initial Public Offering (IPO) of Krsnaa Diagnostics Limited ended on Friday, 6 August 2021.
Sun, Aug 08, 2021
Krsnaa Diagnostics IPO – IPO of Krsnaa Diagnostics Limited ended on 6 August 2021 – Friday. The IPO was subscribed 24.34 times over the three-day period. The response form RIIs was also strong as they subscribed this issue 19.33 times. The non-institutional investors subscribed it 28.17 times while the QIBs subscribed the issue 25.58 times on the NSE
Fri, Aug 06, 2021
On the last day of the subscription, the initial public offer of four companies — Exxaro Tiles, Krsnaa Diagnostics, Devyani International, Windlas Biotech was fully subscribed on August 6. The four offers were launched together on August 4, 2021.
Wed, Aug 04, 2021
KRSNAA Diagnostics Limited IPO – The IPO of KRSNAA Diagnostics Limited opened today. The three-day IPO will end on 6 August. The erstwhile Krsnaa Diagnostics Pvt Ltd company gives in radiology and pathology services. This is what Zee Business Managing Editor Anil Singhvi said
Market Guru said that the company is relatively smaller from its peers - Dr Lal Path Labs and Metropolis Healthcare. But there are interesting aspects about this company. The company has a different business model and they are into value added services. This gives them a higher margin and revenue per customer for those services, Singhvi said
Tue, Aug 03, 2021
Lots of action in the primary markets as 4 IPOs open on Wednesday – 4 July. Devyani International Limited, Krsnaa Diagnostics Limited, Windlas Biotech Limited, Exxaro Tiles Limited will be launching their public issues. From price band to lot size to maximum and minimum subscription amounts, get full details of each IPO here!
Mon, Aug 02, 2021
Promoter of the company is Rajendra Mutha who holds 8,029,920 equity shares, equivalent to 61.82 per cent of the issued, subscribed and paid-up Equity Share capital of the company as per the information filed in the Draft Red Herring Prospectus
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
